Invention Grant
- Patent Title: Crystalline salts of (S)-6-((1 acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
-
Application No.: US15318714Application Date: 2015-06-23
-
Publication No.: US09884846B2Publication Date: 2018-02-06
- Inventor: William M. Clark , Rajendra S. Sathe
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Current Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Current Assignee Address: GB Brentford, Middlesex
- Agent Duke M. Fitch; Kathryn A. Lutomski; Edward R. Gimmi
- International Application: PCT/IB2015/054712 WO 20150623
- International Announcement: WO2015/198229 WO 20151230
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/506 ; A61K9/00
Abstract:
Disclosed are novel crystalline salts of (S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.
Public/Granted literature
Information query
